After Hours
$
52.48
Change
+0.06 +0.10%
Volume
Volume 23,693
Nov 29, 2016, 7:59 p.m.
Quotes are delayed by 20 min
Today's close
$ 57.67
$ 52.42
Change
-5.25 -9.10%
Day low
Day high
$51.55
$57.16
52 week low
52 week high
$50.90
$85.83
Market cap
$6.21B
Average volume
1.94M
P/E ratio
11.76
Rev. per Employee
$646,632
EPS
4.46
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on MNK
-
Mallinckrodt revenue boosted by higher volumes
- MarketWatch.com
-
Mallinckrodt started at outperform with $72 stock price target at Raymond James
- Tomi Kilgore
-
Mallinckrodt stock price target raised to $112 from $103 at Piper Jaffray
- Tomi Kilgore
-
Mallinckrodt sells nuclear imaging business for $690 million
- Tomi Kilgore
-
Mallinckrodt to sell its nuclear imaging business for $690 million to IBA Molecular
- Tomi Kilgore
-
Mallinckrodt started at buy with $95 stock price target at Stifel Nicolaus
- Tomi Kilgore
-
Dow industrials close lower for 7th straight session
- Wallace Witkowski
-
Mallinckrodt shares jump 9.4% in early trade to $73.46 to lead S&P 500 after results
- Mark DeCambre
-
Mallinckrodt foresees higher adjusted earnings
- MarketWatch.com
-
20 beaten-down U.S. stocks expected to rise as much as 98%
- Philip van Doorn
-
Shares of Mallinckrodt jump 4.3% in early trade to $58.64
- Mark DeCambre
-
Mallinckrodt shares soar 8.4% to $65.81 in early trade to lead S&P 500 advancers
- Mark DeCambre
-
Mallinckrodt profit beats, raises outlook
- MarketWatch.com
-
Mylan, Allergan shares fall after Perrigo profit warning
- Tomi Kilgore
-
These companies get the most bang for the buck with their buybacks
- Wallace Witkowski
-
Drugmaker Mallinckrodt shares tumble 13% in early trade
- MarketWatch
-
Mallinckrodt profit beats views; lifts FY guidance
- MarketWatch
- Loading more headlines...
Analyst Ratings
Other News on MNK
-
Mallinckrodt -9% despite better than expected earnings
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Mallinckrodt Shares Tank, Despite Better-Than-Expected Earnings
- TheStreet.com
-
Healthcare Stocks Help Nasdaq Reach New Heights
- TheStreet.com
-
Mallinckrodt Earnings Top, But Stock Dives On Guidance
- Investors Business Daily
-
Mallinckrodt Rocked After Q4 Report
- benzinga.com
-
Mallinckrodt Earnings - Is Acthar In Jeopardy?
- Seeking Alpha
-
Mallinckrodt’s Greater Dependence on Acthar and Generic Business
- MarketRealist.com
-
What Do Analysts Have to Say about Mallinckrodt?
- MarketRealist.com
-
What to Expect from Mallinckrodt in 2016
- MarketRealist.com
-
Acthar’s Higher Exposure to Government-Oriented Franchise
- MarketRealist.com
-
Tiffany In Buy Zone Ahead Of Q3; Autodesk, Splunk Due: Investing Action Plan
- Investors Business Daily
- Loading more headlines...
Earnings Announcement
Press Releases on MNK
-
Mallinckrodt plc Reports Fiscal 2016 Fourth Quarter and Full-Year Results
- PR Newswire - PRF
-
Clinical Data Analysis on Terlipressin Presented at The Liver Meeting®
- PR Newswire - PRF
-
Mallinckrodt Announces U.S. FDA Approval of OFIRMEV® IV Bag Presentation
- PR Newswire - PRF
-
Mallinckrodt To Present At 28th Annual Piper Jaffray Healthcare Conference
- PR Newswire - PRF
-
Mallinckrodt to present at Jefferies 2016 London Healthcare Conference
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
| Avg. APR | Last Week | 6 Months | |
|---|---|---|---|
| Low Interest | 12.00% | 12.00% | 11.96% |
| Business | 13.12% | 13.12% | 13.12% |
| Student | 13.42% | 13.42% | 13.42% |
| Balance Transfer | 14.41% | 14.41% | 14.39% |
| Airline | 15.13% | 15.13% | 15.17% |
| Reward | 15.24% | 15.24% | 15.30% |
| Cash Back | 15.33% | 15.33% | 15.30% |
| Instant Approval | 17.86% | 17.86% | 18.04% |
| Bad Credit | 22.86% | 22.86% | 22.56% |
